Published in Blood Weekly, May 13th, 1996
The protocol has involved use of recombinant human interleukin-11 (rhIL-11), a growth factor that stimulates production of platelets. Dr. Isidore Tepler, Beth Israel Hospital, Boston, Massachusetts, was lead author of a rapid communication on rhIL-11 that was published in the May 1, 1996, issue of Blood (Blood 1996;87:3607-3614).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.